FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126562453> ?p ?o ?g. }

• W3126562453 endingPage "E8" @default.
• W3126562453 startingPage "E8" @default.
• W3126562453 abstract "Glioblastoma is the most frequent primary brain tumor in adults, with a dismal prognosis despite aggressive resection, chemotherapeutics, and radiotherapy. Although understanding of the molecular pathogenesis of glioblastoma has progressed in recent years, therapeutic options have failed to significantly change overall survival or progression-free survival. Thus, researchers have begun to explore immunomodulation as a potential strategy to improve clinical outcomes. The application of oncolytic virotherapy as a novel biological to target pathogenic signaling in glioblastoma has brought new hope to the field of neuro-oncology. This class of immunotherapeutics combines selective cancer cell lysis prompted by virus induction while promoting a strong inflammatory antitumor response, thereby acting as an effective in situ tumor vaccine. Several investigators have reported the efficacy of experimental oncolytic viruses as demonstrated by improved long-term survival in cancer patients with advanced disease. Newcastle disease virus (NDV) is one of the most well-researched oncolytic viruses known to affect a multitude of human cancers, including glioblastoma. Preclinical in vitro and in vivo studies as well as human clinical trials have demonstrated that NDV exhibits oncolytic activity against glioblastoma, providing a promising avenue of potential treatment. Herein, the authors provide a detailed discussion on NDV as a mode of therapy for glioblastoma. They discuss the potential therapeutic pathways associated with NDV as demonstrated by in vitro and in vivo experiments as well as results from human trials. Moreover, they discuss current challenges, potential solutions, and future perspectives in utilizing NDV in the treatment of glioblastoma." @default.
• W3126562453 created "2021-02-15" @default.
• W3126562453 creator A5003120387 @default.
• W3126562453 creator A5041232043 @default.
• W3126562453 creator A5057792364 @default.
• W3126562453 date "2021-02-01" @default.
• W3126562453 modified "2023-10-10" @default.
• W3126562453 title "The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma" @default.
• W3126562453 cites W1575752211 @default.
• W3126562453 cites W1708153904 @default.
• W3126562453 cites W1858161324 @default.
• W3126562453 cites W1910257954 @default.
• W3126562453 cites W1970718186 @default.
• W3126562453 cites W1972455109 @default.
• W3126562453 cites W1986830366 @default.
• W3126562453 cites W1992305685 @default.
• W3126562453 cites W2002726776 @default.
• W3126562453 cites W2015985147 @default.
• W3126562453 cites W2020912978 @default.
• W3126562453 cites W2036490679 @default.
• W3126562453 cites W2049092411 @default.
• W3126562453 cites W2059782190 @default.
• W3126562453 cites W2061410746 @default.
• W3126562453 cites W2086009578 @default.
• W3126562453 cites W2086207573 @default.
• W3126562453 cites W2091980326 @default.
• W3126562453 cites W2095633844 @default.
• W3126562453 cites W2095747507 @default.
• W3126562453 cites W2096287682 @default.
• W3126562453 cites W2099295163 @default.
• W3126562453 cites W2100025280 @default.
• W3126562453 cites W2100381055 @default.
• W3126562453 cites W2116672872 @default.
• W3126562453 cites W2117150286 @default.
• W3126562453 cites W2121623797 @default.
• W3126562453 cites W2123291849 @default.
• W3126562453 cites W2126427198 @default.
• W3126562453 cites W2155844023 @default.
• W3126562453 cites W2157408208 @default.
• W3126562453 cites W2158897346 @default.
• W3126562453 cites W2160874621 @default.
• W3126562453 cites W2164936922 @default.
• W3126562453 cites W2232973457 @default.
• W3126562453 cites W2319926262 @default.
• W3126562453 cites W2415223664 @default.
• W3126562453 cites W2503534199 @default.
• W3126562453 cites W2530037650 @default.
• W3126562453 cites W2747555890 @default.
• W3126562453 cites W2761884169 @default.
• W3126562453 cites W2766767385 @default.
• W3126562453 cites W2796231609 @default.
• W3126562453 cites W2852589091 @default.
• W3126562453 cites W2884990513 @default.
• W3126562453 cites W2891491540 @default.
• W3126562453 cites W2922634583 @default.
• W3126562453 cites W3002733190 @default.
• W3126562453 cites W3033014431 @default.
• W3126562453 cites W3085706233 @default.
• W3126562453 doi "https://doi.org/10.3171/2020.11.focus20842" @default.
• W3126562453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33524945" @default.
• W3126562453 hasPublicationYear "2021" @default.
• W3126562453 type Work @default.
• W3126562453 sameAs 3126562453 @default.
• W3126562453 citedByCount "15" @default.
• W3126562453 countsByYear W31265624532021 @default.
• W3126562453 countsByYear W31265624532022 @default.
• W3126562453 countsByYear W31265624532023 @default.
• W3126562453 crossrefType "journal-article" @default.
• W3126562453 hasAuthorship W3126562453A5003120387 @default.
• W3126562453 hasAuthorship W3126562453A5041232043 @default.
• W3126562453 hasAuthorship W3126562453A5057792364 @default.
• W3126562453 hasBestOaLocation W31265624531 @default.
• W3126562453 hasConcept C121608353 @default.
• W3126562453 hasConcept C126322002 @default.
• W3126562453 hasConcept C203014093 @default.
• W3126562453 hasConcept C2522874641 @default.
• W3126562453 hasConcept C2776194525 @default.
• W3126562453 hasConcept C2778227246 @default.
• W3126562453 hasConcept C49744831 @default.
• W3126562453 hasConcept C502942594 @default.
• W3126562453 hasConcept C509974204 @default.
• W3126562453 hasConcept C535046627 @default.
• W3126562453 hasConcept C71924100 @default.
• W3126562453 hasConcept C82210918 @default.
• W3126562453 hasConceptScore W3126562453C121608353 @default.
• W3126562453 hasConceptScore W3126562453C126322002 @default.
• W3126562453 hasConceptScore W3126562453C203014093 @default.
• W3126562453 hasConceptScore W3126562453C2522874641 @default.
• W3126562453 hasConceptScore W3126562453C2776194525 @default.
• W3126562453 hasConceptScore W3126562453C2778227246 @default.
• W3126562453 hasConceptScore W3126562453C49744831 @default.
• W3126562453 hasConceptScore W3126562453C502942594 @default.
• W3126562453 hasConceptScore W3126562453C509974204 @default.
• W3126562453 hasConceptScore W3126562453C535046627 @default.
• W3126562453 hasConceptScore W3126562453C71924100 @default.
• W3126562453 hasConceptScore W3126562453C82210918 @default.
• W3126562453 hasIssue "2" @default.
• W3126562453 hasLocation W31265624531 @default.

• next